Abstract
As cord blood (CB) enables rapid access and tolerance to HLA mismatches, a number of unrelated CB transplants have reached 30,000. Such transplant activity has been the result of international accreditation programs maintaining highly qualified cord blood units (CBUs) reaching more than 600,000 CBUs stored worldwide. Efforts to increase stem cell content or engraftment rate of the graft by ex vivo expansion, modulation by molecules such as fucose, prostaglandin E2 derivative, complement CD26 inhibitors, or CXCR4/CXCL12 axis have been able to accelerate engraftment speed and rate. Furthermore, introduction of reduced intensity conditioning protocols, better HLA matching, and recognition of the importance of HLA-C have improved CB transplants success by decreasing transplant-related mortality. CB progenitor/stem cell content has been compared with adult stem cells revealing higher long-term repopulating capacity compared to bone marrow-mesenchymal stromal cells and lesser oncogenic potential than progenitor-induced stem cells. This chapter summarizes the advantages and disadvantages of CB compared to adult stem cells within the context of stem cell biology and transplantation.
References
Dec 8, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ian Rogers, Robert F Casper
Jan 18, 2006·Stem Cells·Susanne KernKaren Bieback
Jun 16, 2007·Blood·Claudio G BrunsteinJohn E Wagner
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jon J van RoodAndromachi Scaradavou
Aug 24, 2010·Critical Reviews in Oncology/hematology·Young-June Kim, Hal E Broxmeyer
Dec 15, 2010·Blood·Juliet N BarkerAndromachi Scaradavou
Jun 16, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Junya KandaMitchell E Horwitz
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Doris M PonceJuliet N Barker
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shunro KaiShunichi Kato
Sep 6, 2013·Leukemia·A RuggeriUNKNOWN Eurocord and Acute Leukemia Working Party of European Blood and Marrow Transplant Group
Jan 28, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parastoo B DahiJuliet N Barker
Mar 8, 2014·Frontiers in Immunology·Robert Danby, Vanderson Rocha
Jul 8, 2014·Bone Marrow Transplantation·P B DahiJ N Barker
Jul 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Henk G M Van der ZandenPablo Rubinstein
Sep 4, 2014·Blood·Duncan PurtillJuliet N Barker
Oct 30, 2014·The New England Journal of Medicine·John E WagnerUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Dec 3, 2014·Cytotherapy·Nate WatsonCesar V Borlongan
Aug 8, 2015·Haematologica·Betül OranElizabeth J Shpall
Sep 27, 2015·Life Sciences·Drenka TrivanovićDiana Bugarski
Oct 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Claudio G BrunsteinJohn E Wagner
Dec 24, 2015·Frontiers in Medicine·Rohtesh S MehtaElizabeth J Shpall
Citations
Mar 1, 2016·Frontiers in Medicine·Meral Beksac, Pinar Yurdakul
Aug 31, 2017·Bulletin of Experimental Biology and Medicine·Yu A RomanovG T Sukhikh
Aug 4, 2016·Journal of Cell Communication and Signaling·Lisa Judith Crawford, Alexandra Elizabeth Irvine